Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices

• Published in: The Journal of biological chemistry 1992-03, Vol.267 (8), p.5712-5721
• Main Authors: MCSHAN, W. M, ROSSEN, R. D, LAUGHTER, A. H, TRIAL, J, KESSLER, D. J, ZENDEGUI, J. G, HOGAN, M. E, ORSON, F. M
• Format: Article
• Language: English
• Subjects: Action of physical and chemical agents; Base Sequence; Biological and medical sciences; Biological Transport; Cell Line; Cell Nucleus - metabolism; Circular Dichroism; DNA, Viral - genetics; Fundamental and applied biological sciences. Psychology; HIV-1 - drug effects; HIV-1 - genetics; HIV-1 - physiology; Humans; Kinetics; Microbiology; Molecular Sequence Data; Nucleic Acid Conformation; Oligodeoxyribonucleotides - chemical synthesis; Oligodeoxyribonucleotides - metabolism; Oligodeoxyribonucleotides - pharmacology; Plasmids; Transcription, Genetic - drug effects; Virology; Virus Replication - drug effects
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/s0021-9258(18)42824-4

The effect on human immunodeficiency virus 1 (HIV-1) viral transcription and subsequent gene expression mediated by mixed purine-pyrimidine oligodeoxyribonucleotides (oligodeoxynucleotides) designed to form collinear DNA triplexes with purine-rich elements in the viral promoter was evaluated in intact mammalian cell lines (MT4 and U937). Oligonucleotides HIV31 (5'-GTTTTTGGGTGTTGTGGGTGTGTGTGGTTTG-3') and HIV38 (5'-TGGGTGGGGTGGGGTGGGGGGGTGTGGGGTGTGGGGTG-3') were designed to interact with the transcription initiation site (-16 to + 13) and nuclear factor Sp1 binding site (-81 to -44) of HIV-1, respectively. Oligonucleotides, synthesized with a 3' amine blocking group (5'-R-O-PO2-OCH (CHOH)-CH2-NH+3-3') to prevent degradation by cellular nucleases, were readily taken up by MT4 cells from the culture medium, achieving measured intranuclear concentrations higher than the medium in less than 2 h of incubation. The 3' amine modified oligonucleotides were recoverable from the cells after 24 h as greater than 90% intact material. Treatment of acutely infected MT4 cells with either HIV31 or HIV38 significantly inhibited viral-associated cytopathology and P24 antigen production (p less than 0.001). Additionally, inhibition of P24 antigen release, culture supernatant viral titer, and expression of the intact 9.2-kb HIV-1 mRNA was observed when the chronically infected promonocyte cell line, U937, was treated with 10 microM HIV38. Control oligonucleotides with similar base composition did not inhibit virus expression in either cell line. Furthermore, inhibition of viral expression was not due to alpha-interferon induction resulting from oligonucleotide treatment. Both HIV31 and HIV38 associate with their respective DNA target duplexes at micromolar concentrations, and a strong negative ellipticity near 210 nm, characteristic of DNA triplexes, was observed in the circular dichroism spectrum of either target-oligonucleotide complex. These observations suggest that oligonucleotides, designed to form nucleic acid triplexes with specific proviral target sequences, can selectively inhibit transcription of viral mRNA in intact cells and suppress accumulation of viral products.